Physician

Shawnta Speer Anakwah, M.D.

According to 2025 Medicare claims, Shawnta Anakwah, M.D. (NPI: 1720267040) practices hematology/oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35211-1323.

Anakwah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 326 traditional Medicare patients, billed 16,868 HCPCS/CPT codes, and received $334,040 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,168 prescription claims across 331 beneficiaries totaling $2,883,728 in drug costs, led by Imbruvica (Ibrutinib). 2021 DME data shows 52 claims. Open Payments data shows 25 records totaling $1,036. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $549,887 to $2,883,728. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$956K$1.9M2015 Medicare payment: $58,425 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $43,854 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $48,732 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $56,058 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $519,141 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,912,839 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,805,923 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,292,464 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $770,764 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $334,040 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015327922$58,425
2016262856$43,854
2017315963$48,732
20183251,055$56,058
201956154,429$519,141
2020561185,776$1,912,839
2021562157,070$1,805,923
2022613134,476$1,292,464
2023325101,318$770,764
202432616,868$334,040

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.4M$6.9M2015 Drug cost: $549,887 (USD; Tot_Drug_Cst)2016 Drug cost: $820,308 (USD; Tot_Drug_Cst)2017 Drug cost: $1,192,551 (USD; Tot_Drug_Cst)2018 Drug cost: $2,172,374 (USD; Tot_Drug_Cst)2019 Drug cost: $2,112,867 (USD; Tot_Drug_Cst)2020 Drug cost: $2,711,669 (USD; Tot_Drug_Cst)2021 Drug cost: $2,894,620 (USD; Tot_Drug_Cst)2022 Drug cost: $3,215,878 (USD; Tot_Drug_Cst)2023 Drug cost: $6,872,646 (USD; Tot_Drug_Cst)2024 Drug cost: $2,883,728 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152081,623$549,887
20162361,965$820,308
20172221,648$1,192,551
20182432,177$2,172,374
20192901,804$2,112,867
20202341,566$2,711,669
20212561,798$2,894,620
20222861,780$3,215,878
20232712,634$6,872,646
20243311,168$2,883,728

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.0K$12K2016 Medicare payment: $11,940 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,441 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,861 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,875 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R25$11,940
2017N/R11$207
2018N/RN/RN/R
2019N/R23$2,441
2020N/R12$1,861
2021N/R52$3,875
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2828$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more247380$82
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's84102$13
36415Insertion of needle into vein for collection of blood sample118168$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count130224$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib22630$330,337
BrukinsaZanubrutinib19570$262,060
IbrancePalbociclib14392$216,276
CalquenceAcalabrutinib Maleate14420$191,942
LenalidomideLenalidomide12287$116,575

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$1,036Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shawnta Speer Anakwah, M.D.?

Tedicare shows public-source Medicare data for Shawnta Speer Anakwah, M.D. (NPI 1720267040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shawnta Speer Anakwah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shawnta Speer Anakwah, M.D.?

Shawnta Speer Anakwah, M.D. is linked to BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (billing NPI 1841216389) in the available physician profile data.

Does Shawnta Speer Anakwah, M.D. have Open Payments data?

Shawnta Speer Anakwah, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.